BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2023-11

228 industry Phase 2/3 trial readout(s) and 23 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2023-10 | 2023-12 →

FDA decision events

DateEventStatusCompanyDrugSource
2023-11-01FDA approvalapprovedPHATHOM PHATVOQUEZNAApproved 2023-11-01: VOQUEZNA (NDA215151 ORIG1)
2023-11-01FDA approvalapprovedSANOFI AVENTIS US SNYSARCLISAApproved 2023-11-01: SARCLISA (BLA761113 SUPPL9)
2023-11-03FDA approvalapprovedZYDUS LIFESCIENCESZITUVIMETApproved 2023-11-03: ZITUVIMET (NDA216743 ORIG1)
2023-11-06FDA approvalapprovedASTRAZENECA AZNLYNPARZAApproved 2023-11-06: LYNPARZA (NDA208558 SUPPL28)
2023-11-07FDA AdComheldAdCom 2023-11-07: Radiological Devices Panel of the Medical Devices Advisory Committee
2023-11-07FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2023-11-07: KEYTRUDA (BLA125514 SUPPL148)
2023-11-08FDA approvalapprovedELI LILLY AND CO LLYZEPBOUND ZEPBOUND KWIKPENApproved 2023-11-08: ZEPBOUND; ZEPBOUND (AUTOINJECTOR); ZEPBOUND KWIKPEN (NDA217806 ORIG1)
2023-11-08FDA approvalapprovedTAKEDA PHARMS USA TAKFRUZAQLAApproved 2023-11-08: FRUZAQLA (NDA217564 ORIG1)
2023-11-09FDA approvalapprovedPACIRA PHARMS INC PCRXEXPARELApproved 2023-11-09: EXPAREL (NDA022496 SUPPL44)
2023-11-15FDA approvalapprovedCORMEDIX CRMDDEFENCATHApproved 2023-11-15: DEFENCATH (NDA214520 ORIG1)
2023-11-15FDA approvalapprovedBRISTOL BMYAUGTYROApproved 2023-11-15: AUGTYRO (NDA218213 ORIG1)
2023-11-16FDA AdComheldAdCom 2023-11-16: Oncologic Drugs Advisory Committee
2023-11-16FDA approvalapprovedASTELLASXTANDIApproved 2023-11-16: XTANDI (NDA213674 SUPPL10)
2023-11-16FDA approvalapprovedALVOGENBONSITYApproved 2023-11-16: BONSITY (NDA211939 SUPPL4)
2023-11-16FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2023-11-16: KEYTRUDA (BLA125514 SUPPL143)
2023-11-16FDA approvalapprovedASTRAZENECA AZNTRUQAPApproved 2023-11-16: TRUQAP (NDA218197 ORIG1)
2023-11-16FDA approvalapprovedEVIVE BIOTECHNOLOGYRYZNEUTAApproved 2023-11-16: RYZNEUTA (BLA761134 ORIG1)
2023-11-16FDA approvalapprovedASTELLASXTANDIApproved 2023-11-16: XTANDI (NDA203415 SUPPL22)
2023-11-17FDA AdComheldMerck Sharp & Dohme Corp. MRKAdCom 2023-11-17: Pulmonary-Allergy Drugs Advisory Committee
2023-11-21FDA approvalapprovedTEVA PHARMS INCPACLITAXELApproved 2023-11-21: PACLITAXEL (NDA216338 SUPPL1)
2023-11-27FDA approvalapprovedSPRINGWORKSOGSIVEOApproved 2023-11-27: OGSIVEO (NDA217677 ORIG1)
2023-11-29FDA AdComheldAdCom 2023-11-29: Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee
2023-11-29FDA approvalapprovedTEVA PHARMS INCALVAIZApproved 2023-11-29: ALVAIZ (NDA216774 ORIG1)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2023-11P2OPKO Health, Inc. OPKNCT02500316 Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient ChildrenGrowth Hormone Deficiency (GHD)completed48
2023-11 est.P3Lightpoint Medical LimitedNCT03731026 The LightPath® and 68Ga-RM2 in Breast Cancer StudyBreast Cancerunknown80
2023-11 est.P3EMSNCT03814109 Efficacy and Safety of Leningrado Association in the Treatment of HypertensionArterial Hypertensionwithdrawn
2023-11 est.P1/P2Actinium Pharmaceuticals ATNMNCT03867682 Venetoclax and Lintuzumab-Ac225 in AML PatientsAcute Myeloid Leukemia; Relapsed Adult AMLunknown38
2023-11 est.P2Mucpharm Pty LtdNCT03976973 BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma PeritoneiPseudomyxoma Peritonei; Peritoneal Cancer; Mucinous Adenocarcinoma; Mucinous Tumorunknown62
2023-11 est.P2TaiwanJ Pharmaceuticals Co., LtdNCT04371718 Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)Autoimmune Hepatitisunknown120
2023-11 est.P3pH PharmaNCT04863365 A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular HypertensionPrimary Open Angle Glaucoma; Ocular Hypertensionunknown110
2023-11 est.P1/P2AlaMab Therapeutics (Shanghai) Inc.NCT04886765 A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With OsteosarcomaOsteosarcomaunknown238
2023-11 est.P2National Vaccine and Serum Institute, ChinaNCT05033847 Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years COVID-19 Pneumonia; Coronavirus Infectionsunknown1800
2023-11 est.P2CSPC Ouyi Pharmaceutical Co., Ltd.NCT05047991 Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic APancreatic Cancer Non-resectable; Pancreatic Cancer Metastaticunknown153
2023-11 est.P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05100329 A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic CancerAdvanced Pancreatic Cancerunknown38
2023-11 est.P1/P2Ribon Therapeutics, Inc.NCT05127590 RBN-2397 in Combination With Pembrolizumab in Patients With SCCLAdvanced Squamous Non-Small Cell Lung Carcinomaunknown50
2023-11 est.P1/P2Adaptive Phage Therapeutics, Inc.NCT05269121 Bacteriophage Therapy in First Time Chronic Prosthetic Joint InfectionsProsthetic Joint Infection; Bacterial Infectionswithdrawn
2023-11 est.P2Vanda Pharmaceuticals VNDANCT05344365 A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease PsychosisParkinson Disease Psychosiswithdrawn
2023-11 est.P2/P3Frontier Biotechnologies Inc. ULCCNCT05445934 Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)COVID-19unknown1188
2023-11 est.P1/P2Tracon Pharmaceuticals Inc.NCT05448820 YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic SarcomaAdvanced Sarcoma; Metastatic Sarcoma; Soft Tissue Sarcomaunknown15
2023-11 est.P3DoCare Pharmaceutial Technology Co.,LtdNCT05764668 Efficacy and Safety of Zihua Wenfei Granules in Treatment of Postinfectious Cough (Wind-cold Invading Lungs Syndrome)Coughunknown480
2023-11 est.P1/P2Context Therapeutics Inc. CNTXNCT06938711 A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast CancerBreast Cancerwithdrawn
2023-11-01P1/P2Boehringer IngelheimNCT03861234 A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)Wet Macular Degenerationcompleted43
2023-11-01P2Shanghai HEP Pharmaceutical Co., Ltd.NCT04426968 A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis BHepatitis B, Chroniccompleted96
2023-11-01 est.P1/P2Nature Cell Co. Ltd.NCT04527224 Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 PneumoniaCovid19 Pneumoniaunknown10
2023-11-01P2Seagen, a wholly owned subsidiary of PfizerNCT04579380 Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsUterine Neoplasms; Uterine Cervical Neoplasms; Biliary Tract Neoplasms; Urologic Neoplasms; Carcinomactive not recruiting217
2023-11-01P3POINT Biopharma, a wholly owned subsidiary of Eli Lilly and CompanyNCT04647526 Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal TreatmentMetastatic Castration-Resistant Prostate Canceractive not recruiting455
2023-11-01P3Resilient PharmaceuticalsNCT04714359 A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSDPTSDcompleted87
2023-11-01 est.P1/P2Jiangsu Yahong Meditech Co., Ltd aka AsierisNCT04813107 A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients Muscle Invasive Bladder Cancerunknown79
2023-11-01P2Neuren Pharmaceuticals LimitedNCT05025241 An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)Phelan-McDermid Syndromecompleted18
2023-11-01P3Dong-A ST Co., Ltd.NCT05282069 A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive BladderOveractive Bladdercompleted607
2023-11-01 est.P2CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.NCT05348122 A Study of TG103 Injection in Type 2 Diabetes SubjectsType 2 Diabetes Mellitusunknown240
2023-11-01P3Allergy TherapeuticsNCT05540717 Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass PollenSeasonal Allergic Rhinitis; Rhinoconjunctivitiscompleted555
2023-11-01P3Kalbe International Pte. LtdNCT06128694 Effect of NUTRICAN to Improve Nutritional Status in Cancer PatientsMalnutrition; Protein; Cancer, Lung; Cancer Cervixunknown108
2023-11-01P1/P2Genrix (Shanghai) Biopharmaceutical Co., Ltd.NCT06302374 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy AdultsTetanuscompleted202
2023-11-02P3Ascendis Pharma Endocrinology Division A/S ASNDNCT04615273 A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone DeficiencyGrowth Hormone Deficiency; Endocrine System Diseases; Hormone Deficiencycompleted264
2023-11-02P2NeuroSense Therapeutics Ltd. NRSNNCT05357950 A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy ofAmyotrophic Lateral Sclerosis; ALScompleted69
2023-11-02P3Procter and Gamble PGNCT05619328 A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of DifferenPeripheral Sensory Neuropathy of Different Etiologiescompleted323
2023-11-02P3Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.NCT06212973 A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis PatientsSeasonal Allergic Conjunctivitiscompleted266
2023-11-02P2Glaukos Corporation GKOSNCT06582732 Performance of the Travoprost Intraocular ImplantGlaucoma, Open-Angle; Ocular Hypertensioncompleted210
2023-11-03P2/P3Incyte Corporation INCYNCT03584516 GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host DiseaseChronic Graft-versus-host Diseaseterminated155
2023-11-03P2RemeGen Co., Ltd.NCT04329429 A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract CancerBiliary Tract Cancerunknown57
2023-11-03P2/P3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT04840485 Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing SpondylitisAnkylosing Spondylitiscompleted548
2023-11-03P3Iterum Therapeutics, International LimitedNCT05584657 Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult WomenUrinary Tract Infections; Cystitiscompleted2229
2023-11-03P3Lyndra Inc.NCT05779241 Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005Schizophrenia; Schizoaffective Disordercompleted83
2023-11-03P2Hipra Scientific, S.L.UNCT05981846 A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 YearsSARS CoV 2 Infection; Influenza, Humancompleted279
2023-11-05P3Boehringer IngelheimNCT04509674 EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)Myocardial Infarctioncompleted6522
2023-11-06P1/P2Bio-Thera SolutionsNCT04772105 Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular EdemaDiabetic Macular Edemacompleted60
2023-11-06P2Definium Therapeutics US, Inc. DFTXNCT05200936 Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept TrialADHD; Attention Deficit Disordercompleted53
2023-11-06 est.P3GlaxoSmithKlineNCT05229068 A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During TheirRespiratory Syncytial Virus Infectionswithdrawn
2023-11-06P1/P2Zhejiang Raygene Pharmaceuticals Co., LtdNCT06848556 Evaluate the Effect of Tirazamine on Primary Liver Cancer.Hepato Cellular Carcinoma (HCC)terminated16
2023-11-07P2Taiwan Liposome CompanyNCT03754049 A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the KneeOsteoarthritis of the Kneecompleted102
2023-11-07P1/P2The Emmes Company, LLCNCT03981549 Treatment of Central Retinal Vein Occlusion Using Stem Cells StudyCentral Retinal Vein Occlusioncompleted16
2023-11-07P2Mirum Pharmaceuticals, Inc. MIRMNCT04524390 Evaluation of Maralixibat in Biliary Atresia Response Post-KasaiBiliary Atresiacompleted75
2023-11-07P2AstraZeneca AZNNCT05459688 Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124Hypertensioncompleted175
2023-11-07P1/P2AstraZeneca AZNNCT05460273 A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)Carcinoma, Non-Small-Cell Lung; Triple Negative Breast Canceractive not recruiting119
2023-11-07P3Haisco-USA Pharmaceuticals, Inc.NCT05478174 Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General AnesthesiaGeneral Anesthesiacompleted400
2023-11-07P3Gilead Sciences GILDNCT05603143 Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe IllnessCOVID-19terminated468
2023-11-08P3Sobi, Inc.NCT04516967 Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 MonthsImmune Thrombocytopeniacompleted75
2023-11-08P2Sanofi SNYNCT04572841 Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)Sjögren's Syndrome; Sjogren's Syndromecompleted84
2023-11-08P2AstraZeneca AZNNCT04610892 Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial InfarctionCoronary Heart Disease (CHD)completed423
2023-11-08P3Alexion Pharmaceuticals, Inc.NCT04622046 A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CMSymptomatic Transthyretin Amyloid Cardiomyopathycompleted25
2023-11-08P2Revalesio CorporationNCT04693715 Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular ThrombectomyStroke, Ischemiccompleted83
2023-11-08P2KoBioLabsNCT04911751 A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type PsoriasisPsoriatic Plaquecompleted80
2023-11-08P3LEO PharmaNCT05259722 A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With SeChronic Hand Eczemacompleted513
2023-11-08P3Neurocrine Biosciences NBIXNCT05654870 Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for SchizophreniaSchizophreniaterminated8
2023-11-08P2Technoderma Medicines Inc.NCT05802173 Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic AlopeciaAlopecia, Androgeneticcompleted71
2023-11-08P3Lissette Ariza CorredorNCT06757452 The Effect of Supplementation with Curcuminoids for the Improvement of Musculoskeletal Conditions in Sedentary AdultsSedentariness and Well-beingcompleted34
2023-11-09P1/P2Atara Biotherapeutics ATRANCT03283826 Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis; Secondary Progressive Multiple Sclerosisterminated134
2023-11-09P1/P2Beacon Therapeutics BBTNCT03316560 Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR MutationsX-Linked Retinitis Pigmentosaactive not recruiting29
2023-11-09P2Bristol-Myers Squibb BMYNCT03496168 Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEERHypertrophic Cardiomyopathycompleted13
2023-11-09P3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT04109950 A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With SchizophreniaSchizophreniaterminated463
2023-11-09P2Cassava Sciences, Inc.NCT04388254 Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsAlzheimer Diseasecompleted220
2023-11-09P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT04574284 A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial CancerAdvanced Endometrial Cancercompleted170
2023-11-09P3Novartis Pharmaceuticals NVSNCT04652726 Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial HypercholesterolemiaFamilial Hypercholesterolemia - Heterozygouscompleted141
2023-11-09P2Boehringer IngelheimNCT04771273 A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)Non-alcoholic Steatohepatitis (NASH)completed295
2023-11-09P2RemeGen Co., Ltd.NCT04905212 A Study of Telitacicept for Injection (RC18) in Subjects With IgA NephropathyIgA Nephropathyterminated15
2023-11-09P3UCB Biopharma SRLNCT05067335 A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With OsteoporosisOsteoporosiscompleted327
2023-11-09P3Ionis Pharmaceuticals, Inc. IONSNCT05139810 OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)Hereditary Angioedemacompleted91
2023-11-09P2Hoffmann-La RocheNCT05171777 A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab FormulationNon-small Cell Lung Cancercompleted179
2023-11-09P2Jazz Pharmaceuticals JAZZNCT05733390 A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum DisorderIrritability Associated With Autism Spectrum Disorder; Autism Spectrum Disorder; ASDwithdrawn
2023-11-09P2Apnimed APMDNCT05793684 AD816 Crossover StudyOSA; Obstructive Sleep Apneacompleted25
2023-11-10P2AstraZeneca AZNNCT04039113 Tezepelumab COPD Exacerbation StudyChronic Obstructive Pulmonary Disease (COPD)completed337
2023-11-10P3ActelionNCT04565990 A Study of Selexipag in Participants Who Participated in a Previous Selexipag StudyHypertension, Pulmonarycompleted43
2023-11-10P1/P2Axolotl BiologixNCT05092646 Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle OsteoarthritisAnkle Osteoarthritisterminated12
2023-11-10P2G1 Therapeutics, Inc.NCT05113966 Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast CancerTriple Negative Breast Cancerterminated30
2023-11-10P3Cytokinetics CYTKNCT05186818 Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCMObstructive Hypertrophic Cardiomyopathy (oHCM)completed282
2023-11-10P2Janssen Research & Development, LLCNCT05307692 A Study of Seltorexant in Participants With Probable Alzheimer's DiseaseAlzheimer Diseasecompleted88
2023-11-11P3Novavax NVAXNCT05875701 Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA VaccinesCOVID-19completed147
2023-11-13P3Takeda TAKNCT04759833 A Study of Prucalopride For Functional Constipation in Children and TeenagersConstipationterminated175
2023-11-13P3Agios Pharmaceuticals, Inc. AGIONCT04770753 A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)Non-Transfusion-dependent Alpha-Thalassemia; Non-Transfusion-dependent Beta-Thalassemiaactive not recruiting194
2023-11-13P2IVIEW Therapeutics Inc.NCT05816070 Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial ConjunctivitisAcute Bacterial Conjunctivitiscompleted129
2023-11-13P2Tarsus Pharmaceuticals, Inc. TARSNCT05838170 Study of TP-04 in Participants With Papulopustular RosaceaPapulopustular Rosaceacompleted37
2023-11-14P3UCB Biopharma SRLNCT03598790 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisChronic Plaque Psoriasis; Moderate to Severe Chronic Plaque Psoriasiscompleted1353
2023-11-14P2Alexion Pharmaceuticals, Inc.NCT04304144 A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL AmyloidosisAL Amyloidosiscompleted25
2023-11-14P1/P2Stoke Therapeutics, Inc STOKNCT04442295 An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet SyndromeDravet Syndromecompleted62
2023-11-14P2Sanofi SNYNCT04678856 Dupilumab in CRSsNPChronic Rhinosinusitis Without Nasal Polyps; Sinusitis; Chronic Sinusitis; Sinus Disorder; Respiratocompleted71
2023-11-14P3Novo Nordisk A/S NVONCT05013229 A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in PeopleDiabetes Mellitus, Type 2completed679
2023-11-14P2Ascletis Pharmaceuticals Co., Ltd.NCT05107778 Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBVHepatitis B, Chroniccompleted43
2023-11-14P1/P2LaNova Australia Pty LimitedNCT05188664 Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid TumorsAdvanced Solid Tumorcompleted20
2023-11-14P3Tonix Pharmaceuticals, Inc. TNXPNCT05273749 A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With FibromyalgiaFibromyalgiacompleted457
2023-11-14P2Hipra Scientific, S.L.UNCT05305573 Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.SARS-CoV-2 Infectioncompleted26
2023-11-14P2Ensysce Biosciences ENSCNCT06629402 Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)Acute Paincompleted16
2023-11-15P3Tian Medical Inc.NCT03337620 Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic MigraineHeadache, Migrainecompleted174
2023-11-15P1/P2Hutchmed HCMNCT03903705 : A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid TumorsAdvanced Solid Tumorcompleted348
2023-11-15P3LIB Therapeutics LLCNCT04797247 Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C ReductionCardiovascular Diseases; Hyper-LDL-cholesterolemiaunknown900
2023-11-15P3LIB Therapeutics LLCNCT04806893 Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C ReductionCardiovascular Risk Factor; Cardiovascular Diseases; Cardiovascular Stroke; Hypercholesterolemiaunknown900
2023-11-15P2Vertero TherapeuticsNCT04895215 AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)Autism Spectrum Disorder (ASD)completed156
2023-11-15P3CelgeneNCT05028634 Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated IMultiple Sclerosis; Multiple Sclerosis, Relapsing-Remittingcompleted63
2023-11-15 est.P3OncXerna Theraputics, Inc.NCT05043402 A Study of Navicixizumab in Patients With Platinum Resistant Ovarian CancerOvarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinomaunknown400
2023-11-15P3Mikrobiomik Healthcare Company S.L.NCT05201079 Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs FidaxomicinRecurrent Clostridium Difficile Infection; Primary Clostridium Difficile Infectioncompleted93
2023-11-15P2/P3Novavax NVAXNCT05975060 A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and UnvaccinateCOVID-19completed660
2023-11-16P2RECORDATI GROUPNCT03606408 Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699Cushing's Syndromecompleted127
2023-11-16P2H. Lundbeck A/SNCT05104476 A Study of Lu AF82422 in Participants With Multiple System AtrophyMultiple System Atrophyactive not recruiting64
2023-11-16P1/P2Longboard PharmaceuticalsNCT05364021 Study to Investigate LP352 in Subjects With Developmental and Epileptic EncephalopathiesDevelopmental and Epileptic Encephalopathy; Dravet Syndrome; Lennox Gastaut Syndromecompleted52
2023-11-17P3Novo Nordisk A/S NVONCT01467427 Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.Congenital Bleeding Disorder; Haemophilia Bcompleted25
2023-11-17P1/P2Janssen Research & Development, LLCNCT02908906 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants WitNeoplasmsactive not recruiting234
2023-11-17P3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT03393520 Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation Agitation in Patients With Dementia of the Alzheimer's Typecompleted601
2023-11-17 est.P2Novartis Pharmaceuticals NVSNCT04460729 A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain MetastasesNon-small Cell Lung Carcinoma (NSCLC)withdrawn
2023-11-17P3Xenon Pharmaceuticals Inc. XENENCT04912856 An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEEEpilepsy; Epilepsy in Children; Epilepsy; Seizure; Disease; Brain Diseases; Central Nervous System Dterminated8
2023-11-17P2/P3ModernaTX, Inc.NCT04927065 A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) VariantsSARS-CoV-2completed5161
2023-11-17P2Hoffmann-La RocheNCT04933227 A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic GasStomach Neoplasms; Gastric Cancer; Gastroesophageal Junction Adenocarcinomaterminated29
2023-11-17P3Janssen Research & Development, LLCNCT04951622 A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisMyasthenia Gravisrecruiting199
2023-11-17P3Novo Nordisk A/S NVONCT04970654 A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.Growth Hormone Deficiency in Childrencompleted110
2023-11-17P3Alvotech Swiss AG ALVONCT05155293 Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)Neovascular (Wet) AMDcompleted413
2023-11-17P3Sumitomo Pharma America, Inc.NCT05227209 A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar IDepressive Episodes, Bipolar I Depressionterminated64
2023-11-17P1/P2InventisBio Co., LtdNCT05383898 Study to Evaluate D-1553 in Subjects With Lung CancerNSCLCcompleted225
2023-11-17P2TrueBinding, Inc.NCT05476783 A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's DiseaseAlzheimer's Diseaseterminated119
2023-11-17P2AIM ImmunoTech Inc. AIMNCT05592418 Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID ConditionsPost COVID-19 Condition; Long COVIDcompleted80
2023-11-19P3BiotestNCT05170269 Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)Congenital Cytomegalovirus Infectionterminated48
2023-11-20P1/P2AkesoNCT04444167 A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular CarcinomaHepatocellular Carcinomacompleted59
2023-11-20P3Novartis Pharmaceuticals NVSNCT04486716 A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple SclerosisRelapsing Multiple Sclerosiscompleted111
2023-11-20P2Innovent Biologics (Suzhou) Co. Ltd.NCT04590599 A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed Advanced Cervical Cancercompleted205
2023-11-20P2Pfizer PFENCT05192200 An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent StudyDermatomyositiscompleted24
2023-11-20P3PharmaEssentiaNCT05231044 A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or ScalpActinic Keratosiscompleted108
2023-11-20P2Rakuten Medical, Inc.NCT05265013 ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without MetastasesHead and Neck Cancerterminated16
2023-11-20P2Eli Lilly and Company LLYNCT05516758 A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid ArthritisRheumatoid Arthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Conneterminated491
2023-11-20P1/P2ModernaTX, Inc.NCT05827068 A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy AdultsSeasonal Influenzacompleted698
2023-11-21P3CelgeneNCT03440385 Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's DiseaseCrohn Diseasecompleted606
2023-11-21P3Janssen Research & Development, LLCNCT03596645 A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisColitis, Ulcerativeactive not recruiting84
2023-11-21P3GlaxoSmithKlineNCT04318548 Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate VaccInfections, Meningococcalcompleted945
2023-11-21P1/P2Tenet MedicinesNCT04652570 Efficacy and Safety of VB119 in Subjects With Membranous NephropathyMembranous Nephropathyterminated6
2023-11-21P3GlaxoSmithKlineNCT04719832 Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic PhenotypeAsthmacompleted395
2023-11-21P2Hoffmann-La RocheNCT05009069 A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal CancerRectal Neoplasms; Rectal Canceractive not recruiting58
2023-11-21P2Lallemand Health SolutionsNCT05545813 Impact of Probiotic Supplementation on Cognition and Related Health Outcomes Among Video GamersStress; Attention Disturbancescompleted36
2023-11-21P2Daiichi SankyoNCT05569252 A Study of DS-1211b in Individuals With PseudoXanthoma ElasticumPseudoxanthoma Elasticumcompleted65
2023-11-21P2Supernus Pharmaceuticals, Inc. SUPNNCT05645432 An Open-Label Study Evaluating Brexanolone in Adults With TinnitusTinnituscompleted10
2023-11-21P2Aldeyra Therapeutics, Inc. ALDXNCT05717920 A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)Atopic Dermatitiscompleted8
2023-11-21P2Empros Pharma ABNCT05934110 Study Exploring the Supportive Effect of Acarbose in Weight ManagementOverweight or Obesityunknown320
2023-11-22P1/P2Janssen Vaccines & Prevention B.V.NCT02935686 A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV AlonHealthycompleted155
2023-11-22P1/P2Takeda TAKNCT03648372 A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune SystemNeoplasms; Lymphoma; Hematologic Neoplasmsterminated109
2023-11-22P1/P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT04808570 A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRelapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphomaterminated23
2023-11-22P3AllerganNCT04891419 JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese PopulationTemple Hollowingcompleted168
2023-11-22P3Shanghai Bovax Biotechnology Co., Ltd.NCT05027776 Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 YearsHPV Infections; Cervical Cancer Stage IIa; Vaginal Cancer; Genital Wart; CIN1; CIN2; CIN3unknown1348
2023-11-22P3Arthritis Innovation CorporationNCT05603832 A Phase 3 Study of F14 for Management of Pain Following Total Knee ReplacementPost Operative Paincompleted151
2023-11-22P3Healthgen Biotechnology Corp.NCT06355479 A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With HypoalbuminemiaHypoalbuminemia; Hepatic Cirrhosiscompleted328
2023-11-22P2Wuhan Createrna Science and Technology Co., LtdNCT06920836 QR052107B Tablets in Patients With Subacute Cough of Phase Ⅱ StudyCoughcompleted270
2023-11-23P3Novartis Pharmaceuticals NVSNCT04838613 Study of Diagnostic Performance of [18F]CTT1057 in BCRProstatic Neoplasms; Prostate Cancer; Recurrencecompleted190
2023-11-24P2Nykode Therapeutics ASANCT04405349 Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical CancerCervical Cancer; Cervix Cancercompleted52
2023-11-24P2Janssen Vaccines & Prevention B.V.NCT04765384 A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19)COVID-19 Preventioncompleted51
2023-11-24P3EstetraNCT04792385 Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female AdolescentsSafetycompleted145
2023-11-24P2/P3Novartis Pharmaceuticals NVSNCT04838626 Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors DetectionProstatic Neoplasms; Prostate Cancercompleted195
2023-11-24P3Pfizer PFENCT04927247 A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive CrisesSickle Cell Disease; Vaso-occlusive Crisis; Vaso-occlusive Pain Episode in Sickle Cell Diseaseterminated72
2023-11-24 est.P2/P3Peschke GmbHNCT05255016 Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal UlcersKeratitis; Corneal Ulcerunknown488
2023-11-24 est.P2/P3Peschke GmbHNCT05255107 Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal UlcersKeratitis; Corneal Ulcerunknown468
2023-11-24P2/P3Seelos Therapeutics, Inc.NCT05490563 STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar AtaxiaSpinocerebellar Ataxia Type 3terminated23
2023-11-24P3AkesoNCT05509361 Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With PsoriasisPlaque Psoriasiscompleted950
2023-11-24P2EpiEndo PharmaceuticalsNCT05572333 Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPDChronic Obstructive Pulmonary Disease; COPDcompleted61
2023-11-24P2Lallemand Health SolutionsNCT06057883 Effects Of A Probiotic Formulation On Stress and Skin Health in Younger Adult FemalesStress; Skin Imperfections; Skin Fine Linescompleted35
2023-11-24P3Ocumension Therapeutics (Shanghai) Co., LtdNCT06429306 Study of Dexycu in Treating Intraocular InflammationInflammation; Cataractcompleted285
2023-11-27P2/P3REGENXBIO Inc. RGNXNCT03566043 CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)Mucopolysaccharidosis Type II (MPS II)active not recruiting48
2023-11-27P3Daewoong Pharmaceutical Co. LTD.NCT04784910 Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic UlcerPeptic Ulcercompleted423
2023-11-27P3Novartis Pharmaceuticals NVSNCT04984876 Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut AllergyAllergy, Peanutterminated211
2023-11-27P1/P2SQZ BiotechnologiesNCT05357898 Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid TumorsAdult Solid Tumorterminated20
2023-11-27P3Bristol-Myers Squibb BMYNCT05414175 A Study of Mavacamten in Obstructive Hypertrophic CardiomyopathyCardiomyopathy, Hypertrophic Obstructivecompleted38
2023-11-27P2Addpharma Inc.NCT05631990 A Study to Evaluate the Efficacy and Safety of AD-209Hypertension, Essentialcompleted221
2023-11-27P2Formation Bio, Inc.NCT05870865 A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic DermatitisDermatitis, Atopic; Prurituscompleted144
2023-11-27P3Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT06500689 To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan IsoproxilEssential Hypertensioncompleted366
2023-11-28P1/P2MingSight Pharmaceuticals, IncNCT03492125 A Study Of The Selective PKC-β Inhibitor MS- 553Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Aggressive Lymphomaterminated60
2023-11-28P2Seagen Inc.NCT04032704 A Study of Ladiratuzumab Vedotin in Advanced Solid TumorsSmall Cell Lung Cancer; Non-small Cell Lung Cancer, Squamous; Non-small Cell Lung Cancer, Non-squamoterminated205
2023-11-28P1/P2Galera Therapeutics, Inc.NCT04476797 Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLCSBRT; NSCLC; Non-metastaticterminated47
2023-11-28P1/P2Jounce Therapeutics, Inc.NCT04669899 Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid TumorsCancercompleted190
2023-11-28P3Novartis Pharmaceuticals NVSNCT04971226 A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPChronic Myeloid Leukemia (CML) Philadelphia Chromosome Positiveactive not recruiting405
2023-11-28P1/P2Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.NCT05272813 A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLLLymphocytic Leukemia; Small Lymphocytic Lymphomaterminated13
2023-11-28P2Novartis Pharmaceuticals NVSNCT05454410 Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)Treatment-Resistant Depressioncompleted60
2023-11-28P3Takeda TAKNCT05460325 A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)Hereditary Angioedema (HAE)completed20
2023-11-28P3Gilead Sciences GILDNCT05715528 Study of Obeldesivir in Nonhospitalized Participants With COVID-19COVID-19completed2011
2023-11-28P1/P2MingSight Pharmaceuticals, IncNCT05720052 A Study of MS-553 in Patients With Relapsed or Refractory B-cell LymphomaRelapsed or Refractory B-cell Lymphoma; Diffuse Large B-cell Lymphoma (DLBCL); Follicular Lymphoma (terminated8
2023-11-28P3GeropharmNCT07070752 Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus PatientsType 1 Diabetes Mellitiscompleted224
2023-11-29P2/P3SyneuRx International (Taiwan) CorpNCT02261519 Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in AdultsSchizophreniaterminated280
2023-11-29P3AbbVie ABBVNCT03047395 A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )Psoriasiscompleted2170
2023-11-29P1/P2Bridge Biotherapeutics, Inc.NCT04820023 Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI TreatmentNSCLCterminated45
2023-11-29P2EQRx, Inc.NCT05085002 A Study of Lerociclib in Participants With Advanced Breast CancerAdvanced Breast Cancerterminated100
2023-11-29P3AllerganNCT05088980 Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in Chinese Adult ParticipantInfraorbital Hollowingcompleted160
2023-11-29P3Gilead Sciences GILDNCT05089734 Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Non-Small Cell Lung Canceractive not recruiting603
2023-11-29P1/P2Chengdu Zenitar Biomedical Technology Co., LtdNCT05153343 Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With MyeloproliferativeMyeloproliferative Neoplasm (MPN); Myelofibrosis,MFcompleted31
2023-11-29P2EyePoint Pharmaceuticals, Inc. EYPTNCT05381948 Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)Wet Age-related Macular Degenerationcompleted161
2023-11-29P2Ensol BioscienceNCT05697952 E1K Intra Articular(IA) Treatment for Knee OsteoarthritisOsteoarthrosiscompleted120
2023-11-29P2Caliway Biopharmaceuticals Co., Ltd.NCT05836779 A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)Cellulitecompleted23
2023-11-30P3Beta Pharma ShanghaiNCT03866499 A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer PatientsNSCLCunknown369
2023-11-30P3SeqirusNCT03932682 Efficacy Study With QIVc in Pediatric SubjectsInfluenza, Humancompleted5723
2023-11-30P3Eurofarma Laboratorios S.A.NCT03936218 Goserelin 10.8mg Injection in Treatment of Advanced Prostate CancerAdvanced Prostate Cancercompleted94
2023-11-30 est.P3Incyte Corporation INCYNCT04203511 INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)Non-small Cell Lung Cancerwithdrawn
2023-11-30P1/P2InSightecNCT04417088 Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin MonotherapyRecurrent Glioblastomacompleted28
2023-11-30P1/P2InSightecNCT04440358 Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBMRecurrent Glioblastomacompleted13
2023-11-30P2Lumicell, Inc.NCT04440982 Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer PatientsBreast Cancer; Neoadjuvant Therapyterminated98
2023-11-30P2Jiangsu HengRui Medicine Co., Ltd.NCT04517357 A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer PatientsRelapsed Ovarian Cancercompleted100
2023-11-30P3Savara Inc. SVRANCT04544293 Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)Autoimmune Pulmonary Alveolar Proteinosisactive not recruiting164
2023-11-30P2GlaxoSmithKlineNCT04544956 A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis BHepatitis Bcompleted12
2023-11-30 est.P1/P2Beijing InnoCare Pharma Tech Co., Ltd.NCT04565275 A Study of ICP-192 in Patients With Advanced Solid TumorsAdvanced Solid Tumors; Urothelial Carcinoma; Cholangiocarcinomaunknown45
2023-11-30P2Galera Therapeutics, Inc.NCT04698915 Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic CancerSBRT; Borderline Resectable Pancreatic Cancer; Unresectable Pancreatic Cancerterminated177
2023-11-30P1/P2THERAPIM PTY LTDNCT04814875 A Study to Evaluate the Combination of ATX-101 and Platinum-based ChemotherapyOvarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; High Grade Serious or Endometriterminated16
2023-11-30P3Xiamen Amoytop Biotech Co., Ltd.NCT04846491 A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis BChronic Hepatitis Bcompleted475
2023-11-30P2Redx Pharma LtdNCT04907851 A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)Advanced Solid Tumourscompleted45
2023-11-30P2Endeavor Biomedicines, Inc.NCT04968574 A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosiscompleted41
2023-11-30 est.P2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT05138146 A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the TrSarcoma, Soft Tissueunknown70
2023-11-30P2Alexion Pharmaceuticals, Inc.NCT05218096 Study of ALXN2050 in Adult Participants With Generalized Myasthenia GravisGeneralized Myasthenia Gravis; Myasthenia Gravisterminated70
2023-11-30P3Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. SKBBYNCT05347134 SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast CancerTriple Negative Breast Canceractive not recruiting254
2023-11-30P2Janssen Scientific Affairs, LLCNCT05347485 A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple MyelomaMultiple Myelomacompleted86
2023-11-30 est.P2Aristea Therapeutics, Inc.NCT05448391 A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)Familial Mediterranean Feverwithdrawn
2023-11-30 est.P2DermBiont, Inc.NCT05491603 A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With OnychomycosisOnychomycosissuspended60
2023-11-30P3Handok Inc.NCT05504226 Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and MetforminType 2 Diabetescompleted214
2023-11-30P2Oxular LimitedNCT05512962 Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular EdemaDiabetic Macular Edemacompleted25
2023-11-30P2/P3ACELYRIN Inc.NCT05623345 Psoriatic Arthritis Study of IzokibepPsoriatic Arthritisterminated351
2023-11-30 est.P3Fujian Shengdi Pharmaceutical Co., Ltd.NCT05788588 A Phase Ⅲ Study of HR19006 Injection in Postsurgical Parenteral NutritionParenteral Nutritionunknown240
2023-11-30P2Innovent Biologics (Suzhou) Co. Ltd.NCT05849246 The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based ChemotherNon-squamous Non-small-cell Lung Cancerterminated4
2023-11-30 est.P2AIM Vaccine Co., Ltd.NCT05939648 A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)SARS-CoV-2unknown450
2023-11-30P3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT05943977 A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese ParticipantsKidney Diseases; Kidney Injury; Kidney Failurecompleted121
2023-11-30P2Samsung Bioepis Co., Ltd.NCT06176963 A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVONeovascular Age-related Macular Degeneration; Macular Edema; Retinal Vein Occlusioncompleted34
2023-11-30P3Dobri KiprovNCT06534450 The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And EpigeneticsAgingunknown40
2023-11-30P3Beijing Kawin Technology Share-Holding Co., Ltd.NCT06544551 Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus InfectionChronic Hepatitis B Virus Infectioncompleted336
2023-11-30P3Changchun GeneScience Pharmaceutical Co., Ltd.NCT06984159 The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two InjAdvanced Prostate Cancercompleted137

← 2023-10 | 2023-12 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.